Trademark: SILVAKLENZ
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for SILVAKLENZ
We do not have any records of a proof of use for SILVAKLENZ at this moment.
Possible trademark infringements of SILVAKLENZ
Basic Information about SILVAKLENZ
- Serial Number
- 87324050
- Filing Date
- 03 Feb 2017
- Registration Number
- 5295081
- Registration Date
- 26 Sep 2017
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of SILVAKLENZ on the blockchain with WikiTrademarks.io.
- First use of SILVAKLENZ anywhere
- SILVAKLENZ was first used on 08 Aug 2005 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns SILVAKLENZ?
1. Molecular Therapeutics Athens GA
2. Molecular Therapeutics Athens GA
3. Molecular Therapeutics Athens GA
Correspondent
- Matthew T. Hoots
- Smith Tempel Blaha LLC
- 1600 Parkwood Circle
- Suite 620
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io